Best practice guidance for the use of strategies to improve retention in randomized trials developed from two consensus workshops

por Brueton, Valerie, Stenning, Sally P., Stevenson, Fiona, Tierney, Jayne, Rait, Greta
Publicado 2017

Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMP...

por Cragg, William J, Hurley, Caroline, Yorke-Edwards, Victoria, Stenning, Sally P
Publicado 2020

Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review

por Cragg, William J, Hurley, Caroline, Yorke-Edwards, Victoria, Stenning, Sally P
Publicado 2021

Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system

por Diaz-Montana, Carlos, Cragg, William J., Choudhury, Rahela, Joffe, Nicola, Sydes, Matthew R., Stenning, Sally P.
Publicado 2019

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide an...

por Cafferty, Fay H., White, Jeff D., Shamash, Jonathan, Hennig, Ivo, Stenning, Sally P., Huddart, Robert A.
Publicado 2020

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study

por Stenning, Sally P, Cragg, William J, Joffe, Nicola, Diaz-Montana, Carlos, Choudhury, Rahela, Sydes, Matthew R, Meredith, Sarah
Publicado 2018

Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

por Collins, Vincent Peter, Ichimura, Koichi, Di, Ying, Pearson, Danita, Chan, Ray, Thompson, Lindsay C, Gabe, Rhian, Brada, Michael, Stenning, Sally P
Publicado 2014

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

por Huddart, Robert A., Gabe, Rhian, Cafferty, Fay H., Pollock, Philip, White, Jeff D., Shamash, Jonathan, Cullen, Michael H., Stenning, Sally P.
Publicado 2015

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial

por Hale, Matthew D., Nankivell, Matthew, Hutchins, Gordon G., Stenning, Sally P., Langley, Ruth E., Mueller, Wolfram, West, Nicholas P., Wright, Alexander I., Treanor, Darren, Hewitt, Lindsay C., Allum, William H., Cunningham, David, Hayden, Jeremy D., Grabsch, Heike I.
Publicado 2016

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o...

por Cunningham, David, Stenning, Sally P, Smyth, Elizabeth C, Okines, Alicia F, Allum, William H, Rowley, Sam, Stevenson, Laura, Grabsch, Heike I, Alderson, Derek, Crosby, Thomas, Griffin, S Michael, Mansoor, Wasat, Coxon, Fareeda Y, Falk, Stephen J, Darby, Suzanne, Sumpter, Kate A, Blazeby, Jane M, Langley, Ruth E
Publicado 2017

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

por Joffe, Johnathan K., Cafferty, Fay H., Murphy, Laura, Rustin, Gordon J.S., Sohaib, Syed A., Gabe, Rhian, Stenning, Sally P., James, Elizabeth, Noor, Dipa, Wade, Simona, Schiavone, Francesca, Swift, Sarah, Dunwoodie, Elaine, Hall, Marcia, Sharma, Anand, Braybrooke, Jeremy, Shamash, Jonathan, Logue, John, Taylor, Henry H., Hennig, Ivo, White, Jeff, Rudman, Sarah, Worlding, Jane, Bloomfield, David, Faust, Guy, Glen, Hilary, Jones, Rachel, Seckl, Michael, MacDonald, Graham, Sreenivasan, Thiagarajan, Kumar, Satish, Protheroe, Andrew, Venkitaraman, Ramachandran, Mazhar, Danish, Coyle, Victoria, Highley, Martin, Geldart, Tom, Laing, Robert, Kaplan, Richard S., Huddart, Robert A.
Publicado 2022